On April 3, 2026, InspireMD, Inc. announced that it has entered into an Equity Distribution Agreement with BTIG, LLC, which will act as the sales agent for the company. This agreement allows InspireMD to offer and sell shares of its common stock, with a total offering amount of up to $75 million. The shares will be sold at the company's discretion through BTIG, utilizing an 'at-the-market' offering strategy as defined under the Securities Act. The company intends to use the net proceeds from this offering for various operational needs, including research and development, sales and marketing, and general corporate purposes. The agreement stipulates that BTIG will receive a commission of up to 3% on the gross proceeds from the shares sold. This move is seen as a strategic effort to bolster the company's financial position and support its growth initiatives. The company has previously engaged in similar equity distribution agreements, and this new arrangement follows the termination of a prior agreement with Piper Sandler & Co. The company has assured that it will comply with all regulatory requirements and maintain transparency throughout the process. The effectiveness of this agreement is contingent upon the company's ability to meet certain conditions and regulatory approvals, which are standard in such transactions.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.